Blood Pressure Lowering in Acute Stroke Trial
NCT01400256
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
lack of recruitment/patient population
Conditions
Stroke, Acute
Interventions
DRUG:
Valsartan
Sponsor
Stanford University